Ariosa Diagnostics renforce son équipe de direction en nommant Thomas J. Musci, M.D. au poste de vice-président du développement clinique et des affaires médicales

Télécharger le fichier PDF

San Jose, Calif., May 1, 2012 – Ariosa Diagnostics, Inc., a molecular diagnostics company, is pleased to announce that Thomas J. Musci, M.D. will lead the clinical development and medical affairs of the company.

Dr. Musci is board-certified in Maternal-Fetal Medicine and Genetics and has had an extensive career in academics, private practice and industry. Recognized as a leader in clinical research on prenatal testing, Dr. Musci has served as chair of the Genetics Committee for the American Congress of Obstetricians and Gynecologists (ACOG), and is currently a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics (ACMG). He was co-founder of San Francisco Perinatal Associates, Inc. and retains an appointment as Associate Clinical Professor with the Department of Obstetrics and Gynecology at University of California, San Francisco (UCSF). He recently held the position of Director of Clinical Affairs for Predictive Health with Novartis Diagnostics.

“Dr. Musci’s addition to our team will help us maintain our clinical excellence standard with the HarmonyTM Prenatal Test,” said Ken Song, chief executive officer at Ariosa Diagnostics.

Dr. Musci graduated from Georgetown University School of Medicine in Washington, DC. After obtaining his medical doctorate, he completed his residency in Obstetrics and Gynecology and fellowships in Maternal-Fetal Medicine and Medical Genetics, as well as a post-doctoral fellowship in the Department of Biochemistry and Biophysics, all at UCSF.

Speaking of his new appointment, Dr. Musci stated, “The Harmony test developed by Ariosa represents a revolutionary advance in prenatal testing for common fetal trisomies and is supported by an impressive amount of clinical data. I look forward to helping educate providers, patients and other constituents on how the Harmony test can improve and streamline patient care during pregnancy.”